PATHOPHYSIOLOGY OF PARKINSON'S DISEASE: MAIN FACTOR ASSOCIATED WITH THE DEVELOPMENT OF PARKINSON'S DISEASE IN YOUNG ADULTS

Authors

DOI:

https://doi.org/10.47820/recima21.v3i1.2322

Keywords:

Parkinson's disease, Shaking paralysis, Proteins associated with Parkinson's

Abstract

Parkinson's disease is a chronic and progressive neurodegenerative disease that usually affects elderly people, however, young people are also not exempt from this disease, and may present signs and symptoms in their youth. Discovered by James Parkinson in 1817, it causes loss of neurons in the central nervous system in a region known as the substantia nigra. The present study is an integrative review with the objective of performing a literature review on the main pathological factor associated with the development of Parkinson's Disease in young adults. The study suggests that understanding aspects of the pathophysiology of PD offers conditions to improve the quality of care, aiming not only to treat symptoms, but also to maintain the patient's quality of life.

Downloads

Download data is not yet available.

Author Biographies

  • Ingrid Ariane Ferreira dos Santos

    UNIFSA - Centro Universitário Santo Agostinho

  • Maria Aparecida Freitas Alves da Silva

    UNIFSA - Centro Universitário Santo Agostinho

  • Francisco Adalberto do Nascimento Paz

    UNIFSA - Centro Universitário Santo Agostinho

References

AUGUSTINE, J.; JEREESH, A. S. Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson’s disease using two-layer hybrid feature selection. Gene, v. 823, n. 146366, p. 146366, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35202733/

CUNHA, L. P. et al. Optical coherence tomography in neurodegenerative disorders. Arquivos de neuro-psiquiatria, v. 80, n. 2, p. 180–191, 2022. Disponível em: https://doi.org/10.1590/0004-282X-ANP-2021-0134

FU, Y. et al. Identification of BAG5 as a potential biomarker for Parkinson’s disease patients with R492X PINK1 mutation. Frontiers in neuroscience, v. 16, p. 903958, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35968372/

TRENTIN, S. et al. Evaluation of the complete Sniffin Sticks Test versus its subtests in differentiating Parkinson’s disease patients from healthy controls. Arquivos de neuro-psiquiatria, v. 80, n. 9, p. 908–913, 2022. Disponível em: DOI: 10.1055/s-0042-1755268

YAKŞI, E. et al. Are static posturography-assisted biofeedback exercises effective in Parkinson’s disease? Arquivos de neuro-psiquiatria, v. 80, n. 9, p. 935–943, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36351419/

KURVITS, L. et al. Transcriptomic profiles in Parkinson’s disease. Experimental biology and medicine (Maywood, N.J.), v. 246, n. 5, p. 584–595, 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934142/#bibr2-1535370220967325

RECH, R. S. et al. Fatores associados a fragilidade em pacientes com doenças neurodegenerativas. CoDAS, v. 34, n. 5, p. e20200214, 2022. Disponível em: https://doi.org/10.1590/2317-1782/20212020214

TOLOSA, E. et al. Challenges in the diagnosis of Parkinson’s disease. Lancet neurology, v. 20, n. 5, p. 385–397, 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185633/

PANICKER, N., et al. A biologia celular da doença de Parkinson. JournalofCellBiology. 2021. Disponível em: https://doi.org/10.1590/S0104-42301997000100017

BALESTRINO, R.; SHAPIRA, AHV. Doença de Parkinson. Eur J Neurol. 2020. Disponível em: https://doi.org/10.1111/ene.14108

OLYMEROPOULOS, M.H., et al. Mapeamento de um gene para a doença de Parkinson no cromossomo 4q21-q23. Science.v. 274, p.1197-1199, 1996. Disponível em: https://doi.org/10.1590/0104-4060.138

Published

21/11/2022

How to Cite

PATHOPHYSIOLOGY OF PARKINSON’S DISEASE: MAIN FACTOR ASSOCIATED WITH THE DEVELOPMENT OF PARKINSON’S DISEASE IN YOUNG ADULTS. (2022). RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 3(1), e3112322. https://doi.org/10.47820/recima21.v3i1.2322